BioSyent Inc. (OTCMKTS:BIOYF – Get Free Report) was down 2.5% on Friday . The company traded as low as $9.81 and last traded at $9.81. Approximately 3,436 shares traded hands during trading, an increase of 38% from the average daily volume of 2,493 shares. The stock had previously closed at $10.06.
BioSyent Stock Down 2.5%
The firm’s fifty day moving average is $10.52 and its 200-day moving average is $10.01.
About BioSyent
BioSyent Inc is a specialty biopharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical products and medical devices. The company leverages expertise in regulatory affairs, clinical development and manufacturing to deliver a range of branded and generic therapies across multiple therapeutic areas, with particular emphasis on endocrine disorders, supportive care oncology and dermatology.
BioSyent operates a manufacturing facility in Canada that supports both its proprietary portfolio and contract development and manufacturing services (CDMO) for small-molecule products.
Featured Stories
- Five stocks we like better than BioSyent
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
- 3 ETFs For the Coming Genomics Revolution
- The Energy Trade Is Bigger Than Oil Prices: 3 Stocks to Buy and 2 to Sell
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.
